Merck Sharp & Dohme Corp. v. Alkem Laboratories Ltd. et al
| Merck Sharp & Dohme Corp. |
| Alkem Laboratories Ltd. and S&B Pharma, Inc. |
| 1:2021cv00824 |
| June 4, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 24, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Vanessa O. Omoroghomwan - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certification for Vanessa O. Omoroghomwan)(Silver, Daniel) |
SO ORDERED, re (75 in 20-cv-847-RGA; 36 in 20-cv-1496-RGA; 96 in 20-cv-749-RGA; 166 in 19-cv-319-RGA; 78 in 20-cv-949-RGA; 82 in 20-cv-1099-RGA; 144 in 19-cv-314-RGA; 163 in 19-cv-313-RGA; 30 in 21-cv-315-RGA; 189 in 19-cv-1489-RGA; 10 in 21-cv-824-RGA; 155 in 19-cv-312-RGA; 61 in 20-cv-815-RGA) MOTION for Pro Hac Vice Appearance of Attorney Vanessa O. Omoroghomwan, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 6/24/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms)
|
|
SO ORDERED, re (D.I. 498 in 19-md-2902-RGA; D.I. 9 in 21-cv-824-RGA) Stipulation and Proposed Order Governing Acceptance of Service of Process and Extension of Response to Complaint. Signed by Judge Richard G. Andrews on 6/11/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00824-RGA(nms)
|
| Filing 9 STIPULATION and [Proposed] Order Governing Acceptance of Service of Process and Extension of Response Time to Complaint by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) |
| Filing 8 DECLARATION of Service as to Defendant S&B Pharma, Inc. made on June 8, 2021, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 6/9/2021 (nms). |
| Filing 7 DECLARATION of Service as to Defendant Alkem Laboratories Ltd. made on June 8, 2021, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 6/9/2021 (nms). |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (sam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp. (sam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (sam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than April 26, 2021. Date of Expiration of Patent: November 24, 2026 (May 24, 2027 pediatric exclusivity expiration).Thirty Month Stay Deadline: 10/26/2023. (sam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Filing 1 COMPLAINT filed against Alkem Laboratories Ltd., S&B Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number BDEDC-3629921.) - filed by Merck Sharp & Dohme Corp. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(sam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
